Disposition and safety of inhaled biodegradable nanomedicines

opportunities and challenges

Research output: Contribution to journalReview ArticleResearchpeer-review

24 Citations (Scopus)

Abstract

The inhaled delivery of nanomedicines can provide a novel, non-invasive therapeutic strategy for the more localised treatment of lung-resident diseases and potentially also enable the systemic delivery of therapeutics that are otherwise administered via injection alone. However, the clinical translation of inhalable nanomedicine is being hampered by our lack of understanding about their disposition and clearance from the lungs. This review provides a comprehensive overview of the biodegradable nanomaterials that are currently being explored as inhalable drug delivery systems and our current understanding of their disposition within, and clearance from the lungs. The safety of biodegradable nanomaterials in the lungs is discussed and latest updates are provided on the impact of inflammation on the pulmonary pharmacokinetics of inhaled nanomaterials. Overall, the review provides an in-depth and critical assessment of the lung clearance mechanisms for inhaled biodegradable nanomedicines and highlights the opportunities and challenges for their translation into the clinic.

Original languageEnglish
Pages (from-to)1703-1724
Number of pages22
JournalNanomedicine-Nanotechnology Biology and Medicine
Volume12
Issue number6
DOIs
Publication statusPublished - 1 Aug 2016

Keywords

  • Biodegradable
  • Clearance
  • Drug delivery
  • Inhalation
  • Nanomedicine
  • Pulmonary

Cite this

@article{2b0c157778f44c72a032166b5ccd66c5,
title = "Disposition and safety of inhaled biodegradable nanomedicines: opportunities and challenges",
abstract = "The inhaled delivery of nanomedicines can provide a novel, non-invasive therapeutic strategy for the more localised treatment of lung-resident diseases and potentially also enable the systemic delivery of therapeutics that are otherwise administered via injection alone. However, the clinical translation of inhalable nanomedicine is being hampered by our lack of understanding about their disposition and clearance from the lungs. This review provides a comprehensive overview of the biodegradable nanomaterials that are currently being explored as inhalable drug delivery systems and our current understanding of their disposition within, and clearance from the lungs. The safety of biodegradable nanomaterials in the lungs is discussed and latest updates are provided on the impact of inflammation on the pulmonary pharmacokinetics of inhaled nanomaterials. Overall, the review provides an in-depth and critical assessment of the lung clearance mechanisms for inhaled biodegradable nanomedicines and highlights the opportunities and challenges for their translation into the clinic.",
keywords = "Biodegradable, Clearance, Drug delivery, Inhalation, Nanomedicine, Pulmonary",
author = "Shadabul Haque and Whittaker, {Michael R.} and McIntosh, {Michelle P.} and Pouton, {Colin W.} and Kaminskas, {Lisa M.}",
year = "2016",
month = "8",
day = "1",
doi = "10.1016/j.nano.2016.03.002",
language = "English",
volume = "12",
pages = "1703--1724",
journal = "Nanomedicine-Nanotechnology Biology and Medicine",
issn = "1549-9634",
publisher = "Elsevier",
number = "6",

}

Disposition and safety of inhaled biodegradable nanomedicines : opportunities and challenges. / Haque, Shadabul; Whittaker, Michael R.; McIntosh, Michelle P.; Pouton, Colin W.; Kaminskas, Lisa M.

In: Nanomedicine-Nanotechnology Biology and Medicine, Vol. 12, No. 6, 01.08.2016, p. 1703-1724.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Disposition and safety of inhaled biodegradable nanomedicines

T2 - opportunities and challenges

AU - Haque, Shadabul

AU - Whittaker, Michael R.

AU - McIntosh, Michelle P.

AU - Pouton, Colin W.

AU - Kaminskas, Lisa M.

PY - 2016/8/1

Y1 - 2016/8/1

N2 - The inhaled delivery of nanomedicines can provide a novel, non-invasive therapeutic strategy for the more localised treatment of lung-resident diseases and potentially also enable the systemic delivery of therapeutics that are otherwise administered via injection alone. However, the clinical translation of inhalable nanomedicine is being hampered by our lack of understanding about their disposition and clearance from the lungs. This review provides a comprehensive overview of the biodegradable nanomaterials that are currently being explored as inhalable drug delivery systems and our current understanding of their disposition within, and clearance from the lungs. The safety of biodegradable nanomaterials in the lungs is discussed and latest updates are provided on the impact of inflammation on the pulmonary pharmacokinetics of inhaled nanomaterials. Overall, the review provides an in-depth and critical assessment of the lung clearance mechanisms for inhaled biodegradable nanomedicines and highlights the opportunities and challenges for their translation into the clinic.

AB - The inhaled delivery of nanomedicines can provide a novel, non-invasive therapeutic strategy for the more localised treatment of lung-resident diseases and potentially also enable the systemic delivery of therapeutics that are otherwise administered via injection alone. However, the clinical translation of inhalable nanomedicine is being hampered by our lack of understanding about their disposition and clearance from the lungs. This review provides a comprehensive overview of the biodegradable nanomaterials that are currently being explored as inhalable drug delivery systems and our current understanding of their disposition within, and clearance from the lungs. The safety of biodegradable nanomaterials in the lungs is discussed and latest updates are provided on the impact of inflammation on the pulmonary pharmacokinetics of inhaled nanomaterials. Overall, the review provides an in-depth and critical assessment of the lung clearance mechanisms for inhaled biodegradable nanomedicines and highlights the opportunities and challenges for their translation into the clinic.

KW - Biodegradable

KW - Clearance

KW - Drug delivery

KW - Inhalation

KW - Nanomedicine

KW - Pulmonary

UR - http://www.scopus.com/inward/record.url?scp=84966327454&partnerID=8YFLogxK

U2 - 10.1016/j.nano.2016.03.002

DO - 10.1016/j.nano.2016.03.002

M3 - Review Article

VL - 12

SP - 1703

EP - 1724

JO - Nanomedicine-Nanotechnology Biology and Medicine

JF - Nanomedicine-Nanotechnology Biology and Medicine

SN - 1549-9634

IS - 6

ER -